Monash IVF Group Ltd 2025 AR2
The report outlines Monash IVF Group's financial and operational performance for the fiscal year ended June 30, 2025. Despite challenging market conditions and clinical incidents, the company achieved a 6.7% revenue increase to $271.9 million and grew its clinical pregnancy success rate to 40.3%. The report highlights strategic progress across its core pillars, including doctor partnerships, scientific leadership, and international expansion in Southeast Asia. Additionally, it details the group's sustainability strategy, focusing on delivering safe, effective healthcare services aligned with the UN Sustainable Development Goals.
Company: Monash IVF Group Ltd
Sector: Health Care
Country: Australia
Year: 2025
Type: AR2
Pages: 140
Monash IVF Group Ltd
Annual Report
The report outlines Monash IVF Group's financial and operational performance for the fiscal year ended June 30, 2025. Despite challenging market conditions and clinical incidents, the company achieved a 6.7% revenue increase to $271.9 million and grew its clinical pregnancy success rate to 40.3%. The report highlights strategic progress across its core pillars, including doctor partnerships, scientific leadership, and international expansion in Southeast Asia. Additionally, it details the group's sustainability strategy, focusing on delivering safe, effective healthcare services aligned with the UN Sustainable Development Goals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jul 1, 2024 - Jun 30, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Employees